TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Forearm blood flow response to vasodilators
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Net release of tissue plasminogen activator during bradykinin infusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: emergency operative mortality
Endpoint domain: Mortality/survival
Primary endpoint: velocity and volume of blood flow of the main portal vein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: ability to accomplish additional tasks
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: ability to document
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: ability to provide patient care
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Iohexol clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Median response times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response precision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of rounded TTO responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean blood transfusion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Detection of uveal malignant melanoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean serum level of IL6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean serum uric acid level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Problems with care
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction in Fe(NO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Episodes of persistent severe hypertension
Endpoint domain: Adverse events/effects
Primary endpoint: median nerve sensory latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Phalen and Tinel signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Adequate vessel visualization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Viral load < 200 copies/ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Skin bacterial colonization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Endothelial cell density (ECD) loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of device use failures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to set up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to read IFU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of participants who completed a successful inhalation without any errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient satisfaction with the device
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean reduction in WOMAC pain score at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in SUI symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in symptom distress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cephalic perimeter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Doppler improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients free of emetic symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom-free or satisfactorily improved patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of pain following treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of symptomatic relapse to pre-treatment levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endovascular therapy decision making
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Major Adverse Cardiac Event rate
Endpoint domain: Adverse events/effects
Primary endpoint: Worsening heart failure rehospitalization rate
Endpoint domain: Adverse events/effects
Primary endpoint: Creatinine clearance (Ccr) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Urinary N-acetyl-beta-D-glucosaminidase (NAG) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Prevalence of LD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median cholesterol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Median triglyceride levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Crying duration in infants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Holter-detected ischemic episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: polyp size reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cesarean section (CS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Vaginal delivery < 24 hours (VD < 24 h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Fatty acid composition of serum phospholipids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement in T-scores for executive functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Transition to injecting and regular use of amphetamines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of depression among amphetamine users
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prevalence of tobacco dependence among amphetamine users
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in counselling provided by pharmacies
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Mean duration of arousal from sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean overestimation of systolic blood pressure during sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Median postoperative blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Proportion of patients additionally transfused
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Proportion of children correctly classified and treated in the first 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intrarater and interrater reliability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with the experience
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Systolic AP recordings within ±20% of baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wobble in AP control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of interventions required for controlling AP
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: VAS cosmetic outcome scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: mHCS cosmetic outcome total scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: SSI incidence
Endpoint domain: Adverse events/effects
Primary endpoint: average decline in the composite score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade of muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Good outcome prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to healthy behaviours related to oral hygiene
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recognition of early diagnostic measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: jumping height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Combined Score (TCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily Symptom Score (DSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily Medication Score (DMS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: favorable structural outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood propofol concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Propofol clearance (Cl)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hours during which pain intensity prohibited daily activities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of analgesics consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of days with head pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative appendectomy rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perforation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost of scanning
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence of airway complications
Endpoint domain: Adverse events/effects
Primary endpoint: Microbiological eradication of NG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: swelling degree of reconstructed ears
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: flap temperature of reconstructed ears
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of death or major sensorineural disability
Endpoint domain: Mortality/survival
Primary endpoint: Completion of LTBI treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Persistent ductal response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity in lesion characterisation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade ≥3 radiation-related toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Restoration of normal function of the middle ear
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to symptom relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to minimal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: functional plasma C1-esterase inhibitor levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intra-left AEMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aortic strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aortic distensibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increasing estradiol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: stent-related mortality
Endpoint domain: Mortality/survival
Primary endpoint: morbidity in the form of reduced esophageal perforation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tumor in-growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: provocation dose required to cause a clinically significant improvement of 10% in FEV1 (PD10)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: bioavailability of oral route
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NPS (Normalized Pathological Score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: BWAT total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BWAT score for inflammatory items
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BWAT scores for wound size reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acute PV reconnection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: intraocular inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimum effective anesthetic concentration (ED(50))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ventilatory efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: physical activity patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of transfused patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: HBsAg testing completion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infarct perfusion improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ability to contract the pelvic floor muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported severity of urinary incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attentional bias to threat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2-year cumulative rates of the composite primary outcome
Endpoint domain: Mortality/survival
Primary endpoint: 2-year rates of death from any cause
Endpoint domain: Mortality/survival
Primary endpoint: number of biopsies per person-year of follow-up
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: non-HDL cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Self-rated pain and disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: maximum exercise duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of local signs (redness, induration, swelling, tenderness)
Endpoint domain: Adverse events/effects
Primary endpoint: Rates of systemic signs (irritability, intermittent inconsolable crying, persistent crying)
Endpoint domain: Adverse events/effects
Primary endpoint: Axillary temperature greater than 38 degrees C
Endpoint domain: Adverse events/effects
Primary endpoint: Change in mfERG from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: placenta-mediated complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: IAT recommendation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Viral load <50 copies/ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean increase in CD4(+) T-cell count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time period between ICU admission and alertness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total time of intubation in ICU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: coping with illness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: FIM motor score agreement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in symptoms and expedited recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in Adenovirus titres
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: supplementary oxygen dependency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: pulmonary hemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage of patients requesting sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of successful cecal intubations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-month restenosis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: asymptomatic patients at follow-up
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PUFA intermediates C18:3n-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: PUFA intermediates C20:3n-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: plasma alpha-tocopherol/total lipid ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: length of the third stage of labor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: need for surgical intervention because of retained placenta
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: HRQL deterioration rates
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Support for expanded scope of practice of pharmacists
Endpoint domain: Delivery of care
Primary endpoint: Increase in muscle size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of exercise-induced muscle damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Skeletal-Related Events (SREs)
Endpoint domain: Adverse events/effects
Primary endpoint: total sugar consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: nutritional quality of breakfast
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Retention rates at 1 year
Endpoint domain: Mortality/survival
Primary endpoint: incidence of grades 3/4 toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement of sperm parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: treatment-related adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: partial response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: stable disease for ≥12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: myocardial salvage index (MSI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Overall physical activity level (cpm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intestinal motility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: 24-hour successful abortion rate
Endpoint domain: Mortality/survival
Primary endpoint: retained chorionic villi rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: breast self-examination rates
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: intentions to have a clinical breast examination
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Decrease in uterine volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in volume of the largest leiomyoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amenorrhea rates after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Western Ontario Rotator Cuff (WORC) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Strength of the supraspinatus and infraspinatus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean benzodiazepine dosage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Benzodiazepine cessation proportion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of tTG-based ELISA for gluten sensitivity diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of tTG-based ELISA for gluten sensitivity diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treg/CTL ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: improvement of blood flow characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mortality 0-28 days
Endpoint domain: Mortality/survival
Primary endpoint: Silverman score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes